Back

One-year outcome using a size-adjustable cryoballoon in patients with atrial fibrillation

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Catheter ablation in atrial fibrillation: new technologies Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Yosuke Hayashi

Sakakibara Heart Institute, Tokyo (Japan)

7 More presentations in this session

Presentation thumbnail
Long-term clinical effectiveness of pulsed field ablation in elderly patients with atrial fibrillation: sub-analysis of the global FARADISE registry
Professor A. Dello Russo (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Sex differences in long-term clinical effectiveness after pulsed field ablation to treat atrial fibrillation. Sub-analysis of the global FARADISE registry
Doctor J. Vijgen (Hasselt, BE)
Abstract Slides
Presentation thumbnail
Impact of ablation modality on alternative efficacy endpoint definition of pulmonary vein isolation for atrial fibrillation
Mr F. Jordan (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Procedural characteristics of very high-power short-duration compared to ablation index-guided ablation for pulmonary vein isolation in atrial fibrillation patients
Ms N. Van Pouderoijen (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Significance of pulmonary vein reconnections and extra-pulmonary vein procedures in repeated atrial fibrillation ablation
Doctor S. Kawai (Iizuka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Catheter ablation in atrial fibrillation: new technologies

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Late-Breaking Clinical Trials: atrial fibrillation ablation and rhythm control
thumbnail
Congress Session
Late-breaking science on atrial fibrillation
thumbnail
Congress Presentation
Additional ablation in case of ostial level pulmonary vein isolation or spared carina does not improve 1-year outcome after cryoballoon ablation. Results of the NOCA-AF study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources